Single-use Pumps in the Biopharmaceutical Market Growth and Development Insight - Size, Share, Growth, and Industry Analysis
The recent analytical report published by Markntel Advisors (a leading consulting, data analytics, and market research firm), Single-use Pumps in the Biopharmaceutical Market comprises a detailed study of critical and major aspects of market dynamics, i.e. market trends, size, forecasts, growth factors, challenges, and competitor landscape.
In-Depth
Market Overview of Single-use Pumps in the Biopharmaceutical Industry (2022-2027):
According to the latest report, The Single-use Pumps in the Biopharmaceutical Market is projected to grow at a
CAGR of around 6.21% during the forecast period, 2022-2027. The
report demonstrates the prominent factors propelling the exponential growth of
the Single-use Pumps in the Biopharmaceutical industry.
Key
Takeaways: Beneficial for Stakeholders and Clients:
·
Historical Data: 2017-20
·
Base Year: 2021
·
Forecast Period: 2022-27
·
CAGR – 6.21%
What are the major Driver the Single-use
Pumps in the Biopharmaceutical industry?
Increasing Demand for Biopharmaceutical
Product Manufacturing - Biopharmaceutical product
manufacturing is rapidly growing & becoming increasingly competitive. The
success of the clinical pipeline has led to an unprecedented number of new
biologic launches & an increase in the share of new approvals from the U.S
Food and Drug Administration. In addition to this, there has been significant
growth in the research & development of orphan drugs as well. According to
the European Medicines Agency statistics, 207 initial orphan marketing
authorizations have been granted & 126 active initial authorizations of
orphan drugs are to be marketed as of 2022. Therefore, the clinical research,
as well as commercial manufacturing of orphan & niche drugs, would witness
a substantial increase in the coming years.
Further,
with the increasing market for a biosimilar, orphan drugs, and other
biopharmaceutical products, the demand for single-use systems such as
bioreactors, pumps, containers, etc., for clinical as well as commercial
purposes would experience a significant uptick in demand during the forecasted
years.
Download a sample PDF of this
report to gain insights into the complete report structure - https://www.marknteladvisors.com/query/request-sample/single-use-pumps-in-biopharmaceutical-market.html
✅In case you
missed it, we are currently revising our reports. Click on the below to get the
latest research data with forecast for years 2025 to 2030, including market size,
industry trends, and competitive analysis. It wouldn’t take long for the team
to deliver the most recent version of the report.
Single-use Pumps in the
Biopharmaceutical Market Segmentation
The Single-use
Pumps in the Biopharmaceutical Market analysis of Markntel Advisors explores
the industry by emphasizing the growth parameters and categorizes including
geographical segmentation, to offer a comprehensive understanding of the market
dynamic. The further bifurcations are as
follows:
- By Type
- Peristaltic pumps
- Diaphragm pumps
- Rotary lobe pumps
- Piston pumps
- By Material
- Polypropylene (PP)
- Polyethylene (PE)
- By Application
- Clinical
- Commercial
- By
Bioprocessing
- Upstream bioprocessing
- Downstream Bioprocessing
- By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
As per
the regional aspect, the Single-use Pumps in the Biopharmaceutical Market is
expected to be dominated by North America by capturing the potential market
share.
Explore further details about
this research report - https://www.marknteladvisors.com/research-library/single-use-pumps-in-biopharmaceutical-market.html
Top Companies
in the Single-use Pumps in the Biopharmaceutical Market
PSG Dover, Quantex Arc, Watson Marlow, Colly
Flowtech AB, Levitronix, Pumpcell, Fluid Flow, PROMECON GmbH, CerCell,
ALMATECHNIK AG, Verder International B.V., ProMinent GmbH, Others
Recent Development by Leading
Companies
In 2021, PSG, an operating company of Dover
Corporation, announced the acquisition of Quantex Arc Ltd., which is a provider
of single-use pumping technology. This acquisition would help in expanding the
product portfolio of single-use systems in different biopharma & industrial
markets.
In 2019, Quattroflow, launched the QF30SU
Single-use diaphragm pump for handling a wide variety of pharmaceutical &
biotechnology applications that need lower flow rates.
Why Markntel Advisors Report?
Well-known business Prospects: Our accurate analysis market research report serves
as a treasure map for discovering potential markets and novel product avenues.
Additionally, it facilitates comprehensive comparisons of products and
services.
Thoughtful Customer Insights: A market report provides the marketing department
with an in-depth understanding of customer requirements and desires. This
information is bound to enhance products, adjust pricing, and refine
advertising strategies.
Empowering Data-Backed Judgement: Our comprehensive Market research encompasses a wide
spectrum of activities, including precise market sizing, detailed segment
analysis, accurate demand forecasting, competitor identification, and
meticulous pricing trend monitoring.
Need
personalized insights? Click here to customize this report- https://www.marknteladvisors.com/query/request-customization/single-use-pumps-in-biopharmaceutical-market.html
For Further Queries:
Contact
Us
MarkNtel
Advisors
+1
628 895 8081, +91 120 4278433
Corporate
Office: Office No.109,
H-159,
Sector 63, Noida, Uttar Pradesh - 201301, India
Comments
Post a Comment